Journal of Chemistry
Volume 2016 (2016), Article ID 1739879, 7 pages
http://dx.doi.org/10.1155/2016/1739879

Research Article

A Simple and Convenient Method for Simultaneous Determination of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C

Yu Zhou,¹ Wu Ling Wei,¹ Jiang Xing Hua,² and Qingsheng Fan¹

¹Sino-German Joint Research Institution, Nanchang University, 235 Nanjing East Road, Nanchang 330047, China
²Bureau of Agriculture and Grain of Ganzhou, Changzheng Road, The Municipal Building, Zhanggong District, Ganzhou 341000, China

Received 21 March 2016; Revised 23 May 2016; Accepted 19 July 2016

Academic Editor: Pranav S. Shrivastav

Copyright © 2016 Yu Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

A simple, rapid, and specific HPLC method was established for simultaneous determination of five major lignans (Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C) in Schisandra chinensis. The five lignans can be separated completely on Kromasil C₁₈ column (250 nm × 4.6 nm) and then detected at 254 nm using methanol (mobile phase A) and water (mobile phase B) with gradient elution as the mobile phase at 1.0 mL/min flow rate. The column temperature was 30°C. The method was validated in terms of linearity, precision, stability, repeatability, and recovery. Results showed that the method is accurate and reproducible.

1. Introduction

The dried ripe fruit of Schisandra chinensis (S. chinensis) has been used for many years in traditional Chinese medicine. Modern pharmacological studies show that S. chinensis has many biological activities, such as for liver protection [1], hypnogenesis, sedation [2], antioxidative stress [3], vasodilation, anti-inflammation [4], anticancer, immunity enhancement, and anticardiovascular disease [5]. In addition, this species is approved for common food and health food utilization because of its efficiency and safety. S. chinensis is one of the most widely used and studied herbs in Asia; this herb is added in common food, health food, and Chinese multiherb remedies in China. Therefore, establishing a simple and convenient method for quantitative analysis of the bioactive compounds of S. chinensis is rather important and necessary. The fruit of S. chinensis has been proven to contain a variety of pharmacologically active lignans, particularly those with a dibenzocyclooctadiene skeleton. Most of the pharmacological properties of S. chinensis have been attributed to these compounds. Among the bioactive compounds, Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C are the most effective.

Owing to the importance of lignans, some methods for lignan detection have been developed [6, 7]. Liu et al. established a method of detecting nine lignans in 48 min by HPLC-DAD-MS combined with Chemometrics [8]. Kim et al. established a method to detect three lignans by online TLC-DART-MS [9]. Zhang et al. developed a matrix solid-phase dispersion extraction combined with high-performance liquid chromatography for determination of five lignans from the Schisandra chinensis [10]. Given that most methods require expensive equipment such as mass spectrometry (MS), it only can be used by many researchers equipped with MS [11–13].

Therefore, some simple method which does not need expensive equipment is needed for the researchers.

In the present study, Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were detected by a simple and easy method based on HPLC-DAD. The novel and simple method can be utilized in the study and research of the S. chinensis, especially for the undeveloped and developing areas. And because of the short detection time, it is also useful to the researchers who need to detect their contents often.

2. Experiment

2.1. Reagents

HPLC grade methanol was used in the experiments. Ultrapure water was obtained using the Milli-Q system (Millipore, Bedford, MA, USA) and used in the entire test. Standards for quantitative analysis were purchased from the National Institution for Food and Drug Control.

2.2. Instrumentation and Analytical Conditions

HPLC system 1200 series (Agilent Technologies, USA) equipped with Chemstation B.03.02 software (Agilent Technologies, USA), which were comprised of a quaternary solvent delivery pump, an online vacuum degasser, an autosampler, a thermostated compartment, and diode array detector (DAD), were used for chromatographic analysis. All separation processes were performed using a Kromasil C₁₈ column (250 mm × 4.6 mm i.d. with 5.0 μm particle size).

Mobile phase A was methanol and phase B was water. The linear gradient condition (30% B for 0 min to 8 min; 30% to 20% B for 8 min to 12 min; 20% to 10% B for 12 min to 20 min; 10% B for 20 min to 30 min) was applied for the separation process. The five lignans can be separated completely by employing this process. The flow rate was 1.0 mL/min, and the column temperature was 30°C, which was maintained for the entire experiment. The eluate was monitored at 254 nm, and the injection volume was 20 μL. The peak identification was based on the retention time and DAD spectrum against the standard presented in the chromatogram.

2.3. Preparation of the Standard Solution

Quantification was based on the external standard method. The stock solutions of each analyte were prepared by dissolving these standards in methanol. The solutions were separately and accurately prepared as follows: Schizandrol A (0.0032 g), Schizandrol B (0.0042 g), Schisandrin A (0.0046 g), γ-Schisandrin (0.0032 g), and Schisandrin C (0.0040 g) were placed in centrifugal tubes, in which 2, 2, 2, 2, and 2.5 mL of methanol were then added, respectively. After 10 min ultrasonication, the final concentrations were 1600 μg/mL Schizandrol A, 2100 μg/mL Schizandrol B, 2300 μg/mL Schisandrin A, 1600 μg/mL γ-Schisandrin, and 1600 μg/mL Schisandrin C. All of the solutions were stored at −4°C.

The working standard solutions were prepared using the stock solutions. The appropriate stock solutions and methanol were mixed well. Finally, the working standard solutions (800, 262.5, 287.5, 200, and 200 μg/mL) of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were prepared. Subsequently, the mixed standard work solutions (1.25 μg/mL to 300 μg/mL) of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were prepared by using the working standard solutions. These preparations are presented in Table 1. All of the solutions were stored at −4°C.

Table 1: Concentration of a series of standard mixed solution.

Concentration
1
2
3
4
5
6
7
8

Schizandrol A (μg/mL)
320.0
240.0
160.0
80.0
40
20
10
5.0

Schizandrol B (μg/mL)
105.0
78.8
52.5
26.3
13.1
6.6
3.3
1.6

Schisandrin A (μg/mL)
115.0
86.3
57.5
28.8
14.4
7.2
3.6
1.8

γ-Schisandrin (μg/mL)
80.0
60.0
40.0
20.0
10.0
5.0
2.5
1.3

Schisandrin C (μg/mL)
80.0
60.0
40.0
20.0
10.0
5.0
2.5
1.3

2.4. Sample Extraction Procedure

Dry (without mildew) S. chinensis were pulverized using medicinal herb grinders. The powdered sample was weighed accurately and soaked in 80% ethanol for 12 h (1 : 12 material-to-solvent ratio). The powdered sample was refluxed using 80% ethanol for 2 h; this process was repeated three times at 90°C. The extracts were combined before being filtered by the filter and then diluted with 80% ethanol until the final volume of 0.25 g herbs/mL was reached. The diluted solution was filtered through a syringe filter (0.45 μm) and then stored at −4°C before injection.

3. Results and Discussion

3.1. Wavelength Optimization

The five bioactive compounds were scanned between 190 and 400 nm using the UV detector. The maximum absorbance values of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were 217, 204, 207, 214, and 219 nm, respectively. Given the serious end absorption near 210 nm, the detection wavelength was set at 254 nm, in which all of the compounds have apparent absorption band. The results are shown in Figure 1.

(a)Schizandrol A

(b)Schizandrol B

(c)Schisandrin A

(d)γ-Schisandrin

(e)Schisandrin C

Figure 1: UV scanning spectra of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C.

3.2. Detector Optimization

The DAD detector can detect not only one or few but all wavelengths. Therefore, analyzing the characteristic absorption and retention time of the analyte was easier. A general analysis can be made using the characteristic absorption and retention time. In this way, the error rate is remarkably reduced and conveniently used in the assessment of each chromatographic peak of the corresponding materials.

3.3. Mobile Phase Optimization

Various organic solvents in different ratios resulted in different peak separations. The composition and ratios of the mobile phase were optimized using different organic solvents, which include methanol, acetonitrile, and water in different concentrations. In the present study, the mobile phase composition was selected as mobile phase for the simultaneous analysis because of better resolution and shorter analysis time than other phases. Typical HPLC-PDA chromatograms of the standard samples are presented in Figures 2 and 3.

Figure 2: Chromatograms of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C under optimal chromatographic condition. (a) Schizandrol A, (b) Schizandrol B, (c) Schisandrin A, (d) γ-Schisandrin, and (e) Schisandrin C.

Figure 3: Chromatograms of alcohol extracts of S. chinensis under optimal chromatographic condition.

3.4. Preparation of the Standard Curve

Under optimized chromatographic condition, the mixed working standards with different concentrations were injected (three replicates), and then the peak areas were recorded. Average values for the three repetitions were presented as the final results. The peak area and the corresponding concentration are presented in Table 1. The stand curve is established by linear regression analysis of the concentration and the peak area. The standard curve of each analyte was found to be linear (Table 2).

Table 2: Regression equations, , and linear range of five standards.

Regression equation

Linear range (g/mL)

Schizandrol A

5.000–320.000

Schizandrol B

1.641–105.000

Schisandrin A

1.800–115.000

γ-Schisandrin

1.250–80.000

Schisandrin C

1.250–80.000

3.5. Precision

Precision was measured by intra- and interday variabilities. The mixed working standard solutions of low, medium, and high concentrations were analyzed to calculate the relative standard deviation (RSD). The intraday precision was determined by five-time repeated analysis of same samples. Average values were used in RSD calculation. The RSDs of the low-concentration solutions were 0.47%, 0.77%, 1.72%, 1.62%, and 0.56% (). The RSDs of the medium-concentration solutions were 0.16%, 0.17%, 0.11%, 0.11%, and 0.10% (). Finally, the RSDs of the high-concentration solutions were 0.15%, 0.16%, 0.09%, 0.13%, and 0.13% (). The results are presented in Tables 3–5.

Table 3: Peak area and RSD of intraday precision of low concentration.

RSD (%)

Schizandrol A
239.7
240.4
238
238.3
237.9
0.47

Schizandrol B
59
59.4
58.3
58.7
58.4
0.77

Schisandrin A
88.6
87.6
84.7
86.1
86.4
1.72

γ-Schisandrin
44.4
43.9
43.4
42.9
42.7
1.62

Schisandrin C
44.6
44.5
44.2
44.5
44.9
0.56

Table 4: Peak area and RSD of intraday precision of median concentration.

RSD (%)

Schizandrol A
3697.4
3704.6
3710.5
3705.8
3712.7
0.16

Schizandrol B
911.5
913.2
914.9
914
915.4
0.17

Schisandrin A
1270.1
1272.2
1273.3
1273.9
1272.5
0.11

γ-Schisandrin
672.2
672.6
674
673.5
673.6
0.11

Schisandrin C
693.1
694.2
694.2
694.6
695
0.10

Table 5: Peak area and RSD of intraday precision of high concentration.

RSD (%)

Schizandrol A
14726.3
14727.9
14736.1
14760.9
14775.2
0.15

Schizandrol B
3549.5
3546.8
3551.3
3557.2
3560.7
0.16

Schisandrin A
4911.3
4913.1
4914.4
4918.7
4921.5
0.09

γ-Schisandrin
2624.7
2626.9
2627.4
2630.1
2633.6
0.13

Schisandrin C
2708.6
2710.3
2711.2
2717.8
2713.2
0.13

Interday precision was determined by repeated analysis of similar samples with intraday variabilities (i.e., continuously for three days, once every day). The RSDs of the low-concentration solutions were 0.50%, 0.70%, 0.68%, 0.34%, and 0.67%. The RSDs of the medium-concentration solutions were 0.58%, 0.69%, 0.41%, 0.50%, and 0.63%. Finally, the RSDs of the high-concentration solutions were 0.21%, 0.31%, 0.26%, 0.30%, and 0.27%. Data show that the current method was stable for 24 h and 72 h. The results are presented in Tables 6–8.

Table 6: Peak area and RSD of interday precision of low concentration.

RSD (%)

Schizandrol A
239.7
241.5
242
0.5

Schizandrol B
59.0
59.8
59.6
0.7

Schisandrin A
88.6
87.9
89.1
0.7

γ-Schisandrin
44.4
44.7
44.5
0.3

Schisandrin C
44.6
44.9
44.3
0.7

Table 7: Peak area and RSD of interday precision of median concentration.

RSD (%)

Schizandrol A
3697.4
3732.5
3736.2
0.58

Schizandrol B
911.5
920.6
923.7
0.69

Schisandrin A
1270.1
1280.2
1277.5
0.41

γ-Schisandrin
672.2
677.5
678.5
0.50

Schisandrin C
693.1
699.9
701.4
0.63

Table 8: Peak area and RSD of interday precision of high concentration.

RSD (%)

Schizandrol A
14726.3
14768.4
14787.9
0.21

Schizandrol B
3549.5
3560.2
3571.4
0.31

Schisandrin A
4911.3
4922.4
4936.8
0.26

γ-Schisandrin
2624.7
2634.7
2640.1
0.30

Schisandrin C
2708.6
2714.5
2723.2
0.27

3.6. Stability

To evaluate the stability of the method, the mixed working standard solutions of different concentrations were analyzed at 0, 3, 6, 9, 15, 21, and 24 h at room temperature through the developed method. The peak area was recorded, and RSD was calculated. The RSDs were 0.30%, 0.31%, 0.30%, 0.37%, and 0.48% (), which indicated that the established method was stable in a day. The results are shown in Table 9.

Table 9: Peak area and RSD of stability.

RSD (%)

Schizandrol A
3704.6
3712.7
3704.1
3720.3
3708.2
3732.5
3742.6
0.30

Schizandrol B
913.2
915.4
914
918.2
914.9
920.6
923
0.31

Schisandrin A
1272.2
1272.5
1270.8
1276.2
1270.1
1280.2
1278.9
0.30

γ-Schisandrin
672.6
673.6
676.3
679
677.4
677.5
679.2
0.37

Schisandrin C
694.2
695
698.9
703.1
700.2
699.9
702.1
0.48

3.7. Repeatability

Six portions were accurately weighed from the same S. chinensis sample; the Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C contents were detected through the developed method; the RSDs of the samples were 0.09%, 0.76%, 1.19%, 0.34%, and 0.11%, respectively. Analyte contents were 4.46 mg/g, 2.80 mg/g, 0.70 mg/g, 2.53 mg/g, and 0.26 mg/g, respectively. The results are presented in Table 10.

Table 10: Peak area and RSD of repeatability.

RSD (%)

Schizandrol A
5058.0
5068.6
5071.2
5068.9
5063
5066.4
0.09

Schizandrol B
2388.6
2352.7
2353.3
2359.3
2392.8
2378.4
0.76

Schisandrin A
753.4
772
773.1
773.7
777.5
778.5
1.19

γ-Schisandrin
2061.1
2080.2
2077.9
2078.9
2077.9
2076.6
0.34

Schisandrin C
223.8
223.8
223.9
223.7
223.2
223.7
0.11

3.8. Recoveries

In the recovery test, nine portions from the same sample were accurately weighed. In these portions, the amounts of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were known. After homogenously dividing these portions into three groups, 50%, 100%, and 150% of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C were added separately. The resultant samples were extracted and analyzed using the developed method. The experiments were repeated three times for each level. The peak area was recorded, and then the recovery percent was calculated, which is the ratio of measured and added amounts. As shown in Tables 11–13, the average recovery rate was 98.1% and the average RSD is 1.92%, which indicated that the developed method is reliable and stable.

Table 11: Peak area and RSD of recovery (50%).

1
2
3
Quantity found
Quantity added
Recovery
RSD (%)

Schizandrol (μg/mL)
56.8
57.2
57.3
57.10
57.50
99.30
0.46

Schizandrol B (μg/mL)
34.6
34.3
33.9
34.27
34.90
98.19
1.02

Schisandrin A (μg/mL)
9.5
9.6
9.1
9.40
9.80
95.92
2.81

γ-Schisandrin (μg/mL)
29.8
30.3
30.9
30.33
31.50
96.30
1.82

Schisandrin C (μg/mL)
3.2
3.3
3.3
3.27
3.40
96.08
1.77

Table 12: Peak area and RSD of recovery (100%).

1
2
3
Quantity found
Quantity added
Recovery
RSD (%)

Schizandrol (μg/mL)
113.8
113.6
115.2
114.20
115.0
99.30
0.76

Schizandrol B (μg/mL)
70.1
68.7
67.3
68.70
69.8
98.42
2.04

Schisandrin A (μg/mL)
19.1
18.7
20.3
19.37
19.6
98.81
4.30

γ-Schisandrin (μg/mL)
62.5
60.9
61.7
61.70
63.0
97.94
1.30

Schisandrin C (μg/mL)
6.5
6.9
6.3
6.57
6.8
96.57
4.65

Table 13: Peak area and RSD of recovery (150%).

1
2
3
Quantity found
Quantity added
Recovery
RSD (%)

Schizandrol (μg/mL)
173.6
172.9
174.2
173.57
172.50
100.62
0.37

Schizandrol B (μg/mL)
102.8
103.4
104.1
103.43
104.70
98.79
0.63

Schisandrin A (μg/mL)
28.6
27.9
29.3
28.60
29.40
97.28
2.45

γ-Schisandrin (μg/mL)
92.9
93.8
94.6
93.77
94.50
99.22
0.91

Schisandrin C (μg/mL)
10.4
10.1
9.7
10.07
10.20
98.69
3.49

3.9. Application

By using the developed method, the analyte contents of the herbs from Heilongjiang, Liaoning, Hebei, Shanxi, Henan, and Hubei province in China were measured. Marked differences were observed in the analyte content of these samples. The S. chinensis from Hebei has the highest amount of Schizandrol A, Schizandrol B, and γ-Schisandrin. By comparison, the S. chinensis from Shanxi has the highest amount of Schisandrin A and Schisandrin C. The analyte contents of the herbs from Liaoning and Hebei were similar, in which Schizandrol A, Schizandrol B, and γ-Schisandrin were relatively high. The analyte contents were similar among the herbs from Shanxi, Hubei, and Henan, in which Schizandrol A content was high, whereas the amounts of the other lignans were low. The results are shown in Table 14.

Table 14: Content of Schizandrol A, Schizandrol B, Schisandrin A, Schisandrin B, and Schisandrin C of S. chinensis from six provinces.

Heilongjiang
Liaoning
Hebei
Shanxi
Henan
Hubei

Water content (%)
8.21
10.74
8.02
8.40
9.80
6.98

Schizandrol (mg/g)
2.11
5.10
5.50
0.08
0.01
0.03

Schizandrol B (mg/g)
1.57
3.28
3.40
0.37
0.16
0.06

Schisandrin A (mg/g)
3.02
0.80
1.25
4.85
4.06
4.07

γ-Schisandrin (mg/g)
1.06
2.49
2.62
0.19
—
0.06

Schisandrin C (mg/g)
0.47
0.55
0.48
0.75
0.64
0.60

Total content (mg/g)
8.24
12.21
13.24
6.24
4.87
4.84

4. Conclusion

Given that Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C comprise the majority of the lignans, establishing a convenient and reliable analytical method to detect these lignans is important for the researchers. In this study, a simple method was developed for simultaneous detection of the lignans. Halstead et al. established a method to detect Schizandrol A, Schizandrol B, Schisandrin A, and γ-Schisandrin, in which each analyte can be detected within 28 min to 58 min [14].

Compared with other simple methods that do not need expensive equipment, the method developed in the present study has shorter detection time and can detect more analytes. Lee and Kim established a method to detect nine kinds of lignan, in which the detection time for Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C is 39 min. Compared with previous method, the detection time of the current method is shorter [15]. Tan et al. established a rapid detection method to determine the Schisandrin and Schisantherin A. It just costed 10 mins. Although the analytes were fewer than the essay, the detection time was rather short [16]. Moreover, the developed method exhibited high linearity, repeatability, intraday and interday assay precision, accuracy, and reliability. This method provides a simple, rapid, and sensitive technique for determination of Schizandrol A, Schizandrol B, Schisandrin A, γ-Schisandrin, and Schisandrin C by using HPLC-PDA at a single wavelength (i.e., 254 nm).

Competing Interests

The authors declare that they have no competing interests.

References

O. Wang, Q. Cheng, J. Liu et al., “Hepatoprotective effect of Schisandra chinensis (Turcz.) Baill. lignans and its formula with Rubus idaeus on chronic alcohol-induced liver injury in mice,” Food & Function, vol. 5, no. 11, pp. 3018–3025, 2014.

V. V. Giridharan, R. A. Thandavarayan, S. Arumugam et al., “Schisandrin B ameliorates ICV-infused amyloid β induced oxidative stress and neuronal dysfunction through inhibiting RAGE/NF-κB/MAPK and Up-regulating HSP/beclin expression,” PLoS ONE, vol. 10, no. 11, Article ID e0142483, 2015.

D. Hu, Z. Yang, X. Yao et al., “Dibenzocyclooctadiene lignans from Schisandra chinensis and their inhibitory activity on NO production in lipopolysaccharide-activated microglia cells,” Phytochemistry, vol. 104, no. 8, pp. 72–78, 2014.

Y. S. Kang, M. H. Han, S. H. Hong et al., “Anti-inflammatory effects of Schisandra chinensis (Turcz.) Baill Fruit through the inactivation of nuclear factor-kappaB and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated murine macrophages,” Journal of Cancer Prevention, vol. 19, no. 4, pp. 279–287, 2014.

L. Opletal, M. Křenková, and P. Havlíčková, “Phytotherapeutic aspects of diseases of the circulatory system. 7. Schisandra chinensis (Turcz.) Baill.: its composition and biological activity,” Česká a Slovenská Farmacie, vol. 50, no. 4, pp. 173–180, 2001.

X. Hui, W. Xin, and G. Xin, “Simultaneous determination of five major lignans from schisandrae sphenantherae fructus and schisandrae chinensis fructus by microemulsion liquid chromatography,” Chinese Journal of Information on TCM, vol. 22, no. 5, pp. 94–98, 2015.

Z. J. Bo, L. B. Yue, S. Shibo, D. Yan, K. Zinong, and X. Wei, “Development of an automatic vacuum liquid chromatographic device and its application in the separation and its application in the separation of the components from the Schisandra chinensis,” Chinese Journal of Information on TCM, vol. 33, no. 8, pp. 864–868, 2015.

H. Liu, H. Lai, X. Jia et al., “Comprehensive chemical analysis of Schisandra chinensis by HPLC-DAD-MS combined with chemometrics,” Phytomedicine, vol. 20, no. 12, pp. 1135–1143, 2013.

H. J. Kim, M. S. Oh, J. Hong, and Y. P. Jang, “Quantitative analysis of major dibenzocyclooctane lignans in schisandrae fructus by online TLC-DART-MS,” Phytochemical Analysis, vol. 22, no. 3, pp. 258–262, 2011.

Q. Zhang, W. Zhu, H. Guan et al., “Development of a matrix solid-phase dispersion extraction combined with high-performance liquid chromatography for determination of five lignans from the Schisandra chinensis,” Journal of Chromatography B, vol. 1011, pp. 151–157, 2016.

H. Sterbova, “Determination of lignans in Schisandra chinensis using micellar electrokinetic capillary chromatography,” Electrophoresis, vol. 23, no. 2, pp. 253–258, 2002.

B. Wei, Q. Li, D. Su et al., “Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats,” Journal of Pharmaceutical and Biomedical Analysis, vol. 77, pp. 120–127, 2013.

B.-L. Wang, J.-P. Hu, W. Tan, L. Sheng, H. Chen, and Y. Li, “Simultaneous quantification of four active schisandra lignans from a traditional Chinese medicine Schisandra chinensis(Wuweizi) in rat plasma using liquid chromatography/mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 865, no. 1-2, pp. 114–120, 2008.

C. W. Halstead, S. Lee, C. S. Khoo, J. R. Hennell, and A. Bensoussan, “Validation of a method for the simultaneous determination of four schisandra lignans in the raw herb and commercial dried aqueous extracts of Schisandra chinensis (Wu Wei Zi) by RP-LC with DAD,” Journal of Pharmaceutical and Biomedical Analysis, vol. 45, no. 1, pp. 30–37, 2007.

H. J. Lee and C. Y. Kim, “Simultaneous determination of nine lignans using pressurized liquid extraction and HPLC-DAD in the fruits of Schisandra chinensis,” Food Chemistry, vol. 120, no. 4, pp. 1224–1228, 2010.

X.-H. Tan, J.-M. Tian, Z.-B. Wang, N. Ma, X.-Y. Yang, and D.-S. Zhang, “Quantitative analysis of Schisandrin and Schisantherin A in Schisandra chinensis (Turcz.) Baill,” Food Research and Development, vol. 35, no. 20, pp. 91–93, 2014.